AI Bias Analysis
4 models · Takes ~15 seconds
The inflammatory bowel disease therapy succeeded in its first major testing, setting up a competition with several large drugmakers.
Source
Stat News
Opens original article in a new tab
In a trial, metastatic pancreatic cancer patients on the medicine lived twice as long as those on chemotherapy.
The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.
Who would want to be the head of the FDA's Center for Biologics Evaluation and Research?
A handful of hospitals are launching their own chatbots, a risky bet aimed at better serving current patients and gaining new ones.
